Ozempic and Mounjaro May Carry a Small But Real Hair Loss…

Ozempic and Mounjaro May Carry a Small But Real Hair Loss Risk, New Study Finds GLP-1 medications like semaglutide and tirzepatide have transformed diabetes and obesity treatment. A large new study published in The BMJ adds an important, if modest, side effect to the conversation, an increased risk of hair loss. Researchers analysed electronic health records from Penn Medicine, comparing alopecia rates among adults with type 2 diabetes who started treatment with GLP-1 receptor agonists, SGLT-2 inhibitors, or DPP-4 inhibitors, two other common classes of diabetes medication. The analysis covered patients treated between January 2019 and September 2024, involving tens of thousands of patients across two separate comparisons. Before adjustment, GLP-1 users differed meaningfully from the comparison groups, younger on average, with a notably higher body mass index, and lower rates of cardiovascular and kidney disease. Researchers carefully adjusted for these factors, along with age, sex, ethnicity, other medicat